Internal Medicine, Infectious Disease · Cleveland, OH
NPI
1851355788
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9500 Euclid Ave
Cleveland, OH, 44195
Phone (800) 223-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
443 services
Medicare patients, 2024
116
Average age 69
Drug cost, 2024
$61K
170 prescriptions
Company payments, 2023
$350
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sherif B Mossad was code 99233 (hospital e&m - subsequent), 143 times for 55 patients. In total Sherif B Mossad billed 443 services in 14 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 143 | 55 | $88.00 | $13K |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 101 | 27 | $22.81 | $2,304 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 57 | 13 | $23.04 | $1,313 |
| 99205 Office E&M - New | Facility | 32 | 32 | $137.42 | $4,397 |
| 99213 Office E&M - Established | Facility | 19 | 14 | $42.94 | $816 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 15 | 15 | $12.49 | $187 |
| 99214 Office E&M - Established | Facility | 14 | 13 | $65.38 | $915 |
By year: 2022 $40K for 451 services; 2023 $37K for 521 services; 2024 $28K for 443 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sherif B Mossad prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 20 prescriptions and refills. In total Sherif B Mossad wrote 170 Medicare prescriptions that cost $61K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 20 | 24 | Under 11 | $8,296 |
| Dextrose In Water Dextrose 5 % In Water | 18 | 18 | Under 11 | $1,077 |
| Doxycycline Monohydrate Generic | 14 | 16 | Under 11 | $307 |
| Isoniazid Generic | 14 | 20 | Under 11 | $123 |
| Ceftriaxone Ceftriaxone Sodium | 12 | 12 | Under 11 | $326 |
Brand drugs: 36 claims; generic drugs: 134 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Sherif B Mossad $350 ($350 in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.